PRPH
ProPhase Labs·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Significant Revenue Decline
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PRPH
Prophase Labs, Inc.
A growth oriented and diversified diagnostics, genomics and biotech company
626 RXR Plaza
6th Floor
Uniondale
New York 11556
--
ProPhase Labs, Inc., was founded in Nevada in 1989. Transferred from Nevada to Delaware on June 18, 2015. The company is a growth-oriented, diversified next-generation biotechnology, genomics and diagnostic company that develops and commercializes new drugs, dietary supplements and compounds, and provides contract manufacturing services.
Earnings Call
Company Financials
EPS
PRPH has released its 2025 Q3 earnings. EPS was reported at -0.16, versus the expected -0.11, missing expectations. The chart below visualizes how PRPH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PRPH has released its 2025 Q3 earnings report, with revenue of 883.00K, reflecting a YoY change of -37.64%, and net profit of -6.84M, showing a YoY change of -3.83%. The Sankey diagram below clearly presents PRPH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



